Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension
OBJECTIVES: In patients with advanced liver disease, portal hypertension is an important risk factor, leading to complications such as esophageal variceal bleeding, ascites, and hepatic encephalopathy. This study aimed to determine the diagnostic value of T1 and T2 mapping and extracellular volume fraction (ECV) for the non-invasive assessment of portal hypertension.
METHODS: In this prospective study, 50 participants (33 patients with indication for trans-jugular intrahepatic portosystemic shunt (TIPS) and 17 healthy volunteers) underwent MRI. The derivation and validation cohorts included 40 and 10 participants, respectively. T1 and T2 relaxation times and ECV of the liver and the spleen were assessed using quantitative mapping techniques. Direct hepatic venous pressure gradient (HVPG) and portal pressure measurements were performed during TIPS procedure. ROC analysis was performed to compare diagnostic performance.
RESULTS: Splenic ECV correlated with portal pressure (r = 0.72; p < 0.001) and direct HVPG (r = 0.50; p = 0.003). No significant correlations were found between native splenic T1 and T2 relaxation times with portal pressure measurements (p > 0.05, respectively). In the derivation cohort, splenic ECV revealed a perfect diagnostic performance with an AUC of 1.000 for the identification of clinically significant portal hypertension (direct HVPG ≥ 10 mmHg) and outperformed other parameters: hepatic T2 (AUC, 0.731), splenic T2 (AUC, 0.736), and splenic native T1 (AUC, 0.806) (p < 0.05, respectively). The diagnostic performance of mapping parameters was comparable in the validation cohort.
CONCLUSION: Splenic ECV was associated with portal pressure measurements in patients with advanced liver disease. Future studies should explore the diagnostic value of parametric mapping accross a broader range of pressure values.
KEY POINTS: • Non-invasive assessment and monitoring of portal hypertension is an area of unmet interest. • Splenic extracellular volume fraction is strongly associated with portal pressure in patients with end-stage liver disease. • Quantitative splenic and hepatic MRI-derived parameters have a potential to become a new non-invasive diagnostic parameter to assess and monitor portal pressure.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
European radiology - 31(2021), 1 vom: 04. Jan., Seite 85-93 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mesropyan, Narine [VerfasserIn] |
---|
Links: |
---|
Themen: |
Hypertension |
---|
Anmerkungen: |
Date Completed 14.04.2021 Date Revised 30.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00330-020-07080-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313248494 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM313248494 | ||
003 | DE-627 | ||
005 | 20240330232705.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00330-020-07080-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1356.xml |
035 | |a (DE-627)NLM313248494 | ||
035 | |a (NLM)32749584 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mesropyan, Narine |e verfasserin |4 aut | |
245 | 1 | 0 | |a Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.04.2021 | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVES: In patients with advanced liver disease, portal hypertension is an important risk factor, leading to complications such as esophageal variceal bleeding, ascites, and hepatic encephalopathy. This study aimed to determine the diagnostic value of T1 and T2 mapping and extracellular volume fraction (ECV) for the non-invasive assessment of portal hypertension | ||
520 | |a METHODS: In this prospective study, 50 participants (33 patients with indication for trans-jugular intrahepatic portosystemic shunt (TIPS) and 17 healthy volunteers) underwent MRI. The derivation and validation cohorts included 40 and 10 participants, respectively. T1 and T2 relaxation times and ECV of the liver and the spleen were assessed using quantitative mapping techniques. Direct hepatic venous pressure gradient (HVPG) and portal pressure measurements were performed during TIPS procedure. ROC analysis was performed to compare diagnostic performance | ||
520 | |a RESULTS: Splenic ECV correlated with portal pressure (r = 0.72; p < 0.001) and direct HVPG (r = 0.50; p = 0.003). No significant correlations were found between native splenic T1 and T2 relaxation times with portal pressure measurements (p > 0.05, respectively). In the derivation cohort, splenic ECV revealed a perfect diagnostic performance with an AUC of 1.000 for the identification of clinically significant portal hypertension (direct HVPG ≥ 10 mmHg) and outperformed other parameters: hepatic T2 (AUC, 0.731), splenic T2 (AUC, 0.736), and splenic native T1 (AUC, 0.806) (p < 0.05, respectively). The diagnostic performance of mapping parameters was comparable in the validation cohort | ||
520 | |a CONCLUSION: Splenic ECV was associated with portal pressure measurements in patients with advanced liver disease. Future studies should explore the diagnostic value of parametric mapping accross a broader range of pressure values | ||
520 | |a KEY POINTS: • Non-invasive assessment and monitoring of portal hypertension is an area of unmet interest. • Splenic extracellular volume fraction is strongly associated with portal pressure in patients with end-stage liver disease. • Quantitative splenic and hepatic MRI-derived parameters have a potential to become a new non-invasive diagnostic parameter to assess and monitor portal pressure | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Hypertension | |
650 | 4 | |a Liver cirrhosis | |
650 | 4 | |a Magnetic resonance imaging | |
650 | 4 | |a Portal | |
700 | 1 | |a Isaak, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Faron, Anton |e verfasserin |4 aut | |
700 | 1 | |a Praktiknjo, Michael |e verfasserin |4 aut | |
700 | 1 | |a Jansen, Christian |e verfasserin |4 aut | |
700 | 1 | |a Kuetting, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Meyer, Carsten |e verfasserin |4 aut | |
700 | 1 | |a Pieper, Claus C |e verfasserin |4 aut | |
700 | 1 | |a Sprinkart, Alois M |e verfasserin |4 aut | |
700 | 1 | |a Chang, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Maedler, Burkhard |e verfasserin |4 aut | |
700 | 1 | |a Thomas, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Kupczyk, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Attenberger, Ulrike |e verfasserin |4 aut | |
700 | 1 | |a Luetkens, Julian A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European radiology |d 1991 |g 31(2021), 1 vom: 04. Jan., Seite 85-93 |w (DE-627)NLM087691310 |x 1432-1084 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2021 |g number:1 |g day:04 |g month:01 |g pages:85-93 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00330-020-07080-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2021 |e 1 |b 04 |c 01 |h 85-93 |